Summary
Amgen Inc. (AMGN) filed an 8-K on February 20, 2007, reporting key amendments to its Amended and Restated Bylaws, effective February 14, 2007. The most significant change is the adoption of a majority voting standard for directors in uncontested elections. This means that in such elections, a director nominee must receive more votes 'for' than votes 'against' to be elected. If a nominee fails to achieve this majority, they are required to tender their resignation, which the Board of Directors will then review and decide upon within 90 days, with the decision and rationale to be publicly disclosed. Additionally, the company amended its bylaws to allow the Board of Directors to set the size of the Board by resolution, removing the need for a bylaw amendment. This provides greater flexibility in managing board composition. These changes reflect an effort to enhance corporate governance and shareholder engagement, particularly concerning director accountability.
Key Highlights
- 1Amgen Inc. adopted a majority voting standard for directors in uncontested elections, replacing the previous plurality standard.
- 2Under the new majority voting rule, directors failing to receive more 'for' than 'against' votes in an uncontested election must tender their resignation.
- 3The Board will review tendered resignations and publicly disclose its decision and rationale within 90 days.
- 4The plurality voting standard remains in place for contested director elections.
- 5The company's bylaws were amended to grant the Board the authority to determine its size by resolution, rather than requiring a bylaw amendment.
- 6These bylaw amendments became effective upon adoption by the Board on February 14, 2007.
- 7A press release dated February 15, 2007, further details these bylaw amendments regarding majority voting.